Maybridge 3


Number of compounds

7,639

Plate Numbers

1431-1452 (22 Plates)

Concentration Information

5 mg/ml in DMSO

Plate Format

384-well plate

Plates 1431-1451:
Columns 23-24 (empty)

click plate image to enlarge


Plate 1452:
Column 2 [B, D, F, H, J, L, N, P] (empty)
Column 4 [B, D, F, H, J, L, N, P] (empty)
Column 6 [B, D, F, H, J, L, N, P] (empty)
Column 8 [B, D, F, H, J, L, N, P] (empty)
Column 10 [B, D, F, H, J, L, N, P] (empty)
Column 12 [B, D, F, H, J, L, N, P] (empty)
Column 14 [B, D, F, H, J, L, N, P] (empty)
Column 16 [B, D, F, H, J, L, N, P] (empty)
Column 17 [P] (empty)
Columns 18-22 [B, D, F, H, J, L, N, P] (empty)
Columns 23-24 (empty)

Click plate image to enlarge

This collection was purchased jointly with the New England Regional Center of Excellence in Biodefense and Emerging Infectious Diseases (NERCE) and the Laboratory for Drug Discovery for Neurodegeneration (LDDN) in June 2004 . Funding was provided by NERCE and the Dana Farber/Harvard Cancer Center (DF/HCC) Cancer Drug Assays program (CDA). With the assistance of Dr. Tudor Oprea at the University of New Mexico, these compounds were specifically chosen to increase the overall diversity of the ICCB-Longwood collection, and were also selected for favorable physico-chemical properties, such as solubility, decreased toxicity, and increased stability.

Order Maybridge Compounds

Maybridge Ltd.
Trevillett, Tintagel
Cornwall PL34 0HW
England

contact: Katrina Ferrett
tel. : +44 1840 772043 or +44 1866 2053502
e-mail: katrina.ferrett@maybridge.com